BayWa’s €2.7 Billion Gap Widens as Bank Deadline Looms and Legal Troubles Mount

The clock is ticking for BayWa. By the end of April, the German agricultural and energy group must book roughly €107 million — €45 million from the Cefetra sale and €62 million from repaid shareholder loans. That might sound like progress. But against a financing shortfall of €2.7 billion, it’s little more than a negotiating chip with the lender banks that hold the company’s fate in their hands.

The Bank Decision That Could Sink Everything

DZ Bank and HVB are the gatekeepers. They maintain the standstill agreement that keeps BayWa afloat — and if they refuse to extend it through autumn 2026, the entire restructuring plan collapses on the spot. A decision is expected within weeks.

The original rescue blueprint has already been shredded. The planned sale of a 51% stake in the renewable energy subsidiary BayWa r.e. was supposed to generate up to €1.7 billion by 2028. That deal fell apart after the US scrapped subsidies for renewable energy in early 2025, hammering project developers and destroying the valuation assumptions underpinning the transaction.

So far, asset sales including Cefetra have secured liability reductions of €1.3 billion. That leaves a yawning gap. The next big disposal candidate is T&G Global, the New Zealand fruit trading arm that markets apple brands like Envy and Jazz across more than 60 countries. Goldman Sachs was mandated in March 2026 to find a buyer for BayWa’s 74% stake. T&G posted revenue of $1.3 billion in 2024, and analysts expect proceeds of around €300 million. But the process is already complicated — minority shareholder Joy Wing Mau Group from Hong Kong, which holds nearly 20%, is said to be obstructing the sale. T&G itself has stressed that no decision has been made.

Regulatory Probes and Auditor Fallout

The financial crisis is not BayWa’s only headache. Germany’s financial regulator BaFin ordered a special audit of the 2023 consolidated financial statements in November 2024, citing missing disclosures on credit terms and refinancing risks tied to a €500 million bond and short-term debt instruments worth €632 million. The fallout has been severe: PricewaterhouseCoopers has lost its audit mandate, and BayWa’s management is examining claims for damages against the former auditors. Meanwhile, law firm TILP is preparing lawsuits for shareholders who invested between early 2022 and January 2026.

Should investors sell immediately? Or is it worth buying BayWa?

The pain is spreading to the cooperative banking sector. Bavarian Volksbanken and Raiffeisenbanken have already written down €132 million on a promissory note loan, and GVB President Stefan Müller has publicly warned that a total write-off is possible.

Tighter Oversight, Leaner Targets

Internally, BayWa’s supervisory board is tightening control. The approval threshold for transactions has been slashed from €200 million to €50 million. Three board members have recently departed, and their successors require confirmation at the 2026 annual general meeting.

The financial targets have been dramatically reset. BayWa has scrapped its 2026 forecast entirely. The adjusted EBITDA target for 2027 stands at around €140 million — a fraction of what the group once aimed for. By the end of 2028, the company plans to concentrate on four core business areas, cut roughly 1,300 jobs, and reduce revenue to about €10 billion from a previous €24 billion.

Investors Left in the Dark Until Late 2026

Two milestones will determine the trajectory: the bank agreement and the audited 2025 annual report. Neither is expected before the fourth quarter of 2026, partly because the outstanding revaluation of BayWa r.e. is delaying the financial statements. Until then, the standstill agreement is the only safety net — and investors must navigate without a reliable data foundation.

The stock trades at €14.40, down roughly 14% since the start of the year and more than 33% below its 52-week high of €21.50. For shareholders, the coming weeks will be decisive: if the banks blink, BayWa buys time. If they don’t, the restructuring falls apart before it ever really began.